Abstract
Malignant hyperthermia (MH) is a complex pharmacogenetic disorder of muscle metabolism. To more closely examine the complexities of MH and other related muscle disorders, the Malignant Hyperthermia Association of the United States (MHAUS) recently sponsored a scientific conference at which an interdisciplinary group of experts gathered to share new information and ideas. In this Special Article, we highlight key concepts and theories presented at the conference along with exciting new trends and challenges in MH research and patient care.
Original language | English (US) |
---|---|
Pages (from-to) | 1108-1109 |
Number of pages | 2 |
Journal | Anesthesia and Analgesia |
Volume | 113 |
Issue number | 5 |
DOIs | |
State | Published - Nov 2011 |
Fingerprint
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
Cite this
Future directions in malignant hyperthermia research and patient care. / Hirshey Dirksen, Sharon J.; Larach, Marilyn Green; Rosenberg, Henry; Brandom, Barbara W.; Parness, Jerome; Lang, Robert Scott; Gangadharan, Meera; Pezalski, Tyler.
In: Anesthesia and Analgesia, Vol. 113, No. 5, 11.2011, p. 1108-1109.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Future directions in malignant hyperthermia research and patient care
AU - Hirshey Dirksen, Sharon J.
AU - Larach, Marilyn Green
AU - Rosenberg, Henry
AU - Brandom, Barbara W.
AU - Parness, Jerome
AU - Lang, Robert Scott
AU - Gangadharan, Meera
AU - Pezalski, Tyler
PY - 2011/11
Y1 - 2011/11
N2 - Malignant hyperthermia (MH) is a complex pharmacogenetic disorder of muscle metabolism. To more closely examine the complexities of MH and other related muscle disorders, the Malignant Hyperthermia Association of the United States (MHAUS) recently sponsored a scientific conference at which an interdisciplinary group of experts gathered to share new information and ideas. In this Special Article, we highlight key concepts and theories presented at the conference along with exciting new trends and challenges in MH research and patient care.
AB - Malignant hyperthermia (MH) is a complex pharmacogenetic disorder of muscle metabolism. To more closely examine the complexities of MH and other related muscle disorders, the Malignant Hyperthermia Association of the United States (MHAUS) recently sponsored a scientific conference at which an interdisciplinary group of experts gathered to share new information and ideas. In this Special Article, we highlight key concepts and theories presented at the conference along with exciting new trends and challenges in MH research and patient care.
UR - http://www.scopus.com/inward/record.url?scp=80055076937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80055076937&partnerID=8YFLogxK
U2 - 10.1213/ANE.0b013e318222af2e
DO - 10.1213/ANE.0b013e318222af2e
M3 - Article
C2 - 21709147
AN - SCOPUS:80055076937
VL - 113
SP - 1108
EP - 1109
JO - Anesthesia and Analgesia
JF - Anesthesia and Analgesia
SN - 0003-2999
IS - 5
ER -